ka.roos
Submits third-party assay reports on material purchased directly. Based in Zadar.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.69%
n=9
Suppliers covered
6
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042876 | TB-500 | GGPeps | GGPE-2601-B2671 | PeptideMeter | 2026-Q2 | 99.43 | 4.24 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041523 | Tirzepatide | QSC | QSC-2511-S6768 | VendorInvestigate | 2025-Q4 | 99.93 | 4.70 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020997 | Semaglutide | WXT | WXT-2507-N3348 | Janoshik | 2025-Q4 | 97.41 | 4.71 | 94.9 | Buyer-sourced | 0 | PASS |
| AX-2025-019426 | L-Glutathione (reduced) | HYB | HYB-2502-S7614 | Nordanalyt | 2025-Q2 | 99.35 | 8.00 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019209 | Tirzepatide | SinoPep | SNP-2502-X4903 | Janoshik | 2025-Q2 | 98.66 | 6.83 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-019352 | BPC-157 | HYB | HYB-2502-R6185 | Janoshik | 2025-Q1 | 99.77 | 4.70 | 101.2 | Buyer-sourced | 1 | FAIL |
| AX-2025-020512 | MOTS-c | SSA | SSA-2501-M6154 | VendorInvestigate | 2025-Q1 | 97.92 | 3.08 | 100.6 | Buyer-sourced | 0 | FAIL |
| AX-2024-004296 | Retatrutide | QSC | QSC-2411-C7111 | PeptideMeter | 2024-Q4 | 98.69 | 3.43 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004503 | Retatrutide | HYB | HYB-2407-W6594 | Medutest | 2024-Q3 | 98.35 | 5.64 | 101.2 | Buyer-sourced | 0 | PASS |